Why is Remus Pharma. falling/rising?

As of 26-Jun, Remus Pharmaceuticals Ltd is experiencing a price increase, with its current price at 1,959.45, reflecting a rise of 79.0 points or 4.2%. The stock has outperformed its sector by 4.12% today, and there has been a notable increase in investor participation, with delivery volume rising by 83.1% against the 5-day average. In terms of performance over the past week, the stock has gained 5.92%, although it has seen a decline of 1.21% over the past month and a significant drop of 21.54% year-to-date. The stock is currently trading above its 5-day and 20-day moving averages, indicating some positive momentum, but it remains below its longer-term moving averages, suggesting potential resistance at higher price levels. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Remus Pharmaceuticals' short-term performance has outpaced the Sensex, which has increased by 3.05% over the same week. However, the stock's year-to-date performance is significantly lagging behind the benchmark, which has gained 8.05%. This contrast highlights the stock's volatility and challenges in maintaining upward momentum despite recent gains. Overall, while the stock is currently rising, its longer-term performance remains a concern compared to the broader market trends.